Ƶ

Clonazepam Recall Expands; Lipid Depression Screening; Period Pain and Depression

— News and commentary from the psychiatry world

Ƶ MedicalToday
Illustration of a brain shaped maze.

The FDA broadcast Endo's expanded , used for panic disorder among other conditions, due to potential product carton strength mislabeling.

After controlling for immortal time bias, high-dose antipsychotic and benzodiazepine use in a large study of people with schizophrenia. (JAMA Network Open)

Researchers suggested in the general population. (eBioMedicine)

Three-fourths of U.S. women and nearly two-thirds of men said about mental health in addition to physical health concerns, according to a Gallup poll.

FDA researchers on how the asthma drug montelukast (Singulair) affects the brain; the drug has carried a black box warning about neuropsychiatric effects since 2020. (Reuters)

U.K. Biobank data showed that with a higher risk of major adverse cardiovascular events. (Journal of Epidemiology and Community Health)

A Mendelian randomization study suggested a causal relationship . (Briefings in Bioinformatics)

Digital devices like smartwatches and fitness trackers may help in people with bipolar disorder. (Acta Psychiatrica Scandinavica)

Could a "yoga pill" help ? (Los Angeles Times)

In response to a New York City stabbing spree last week that left three people dead, Mayor Eric Adams that would clarify and expand criteria for individuals to be hospitalized for psychiatric care against their will. (Gothamist)

One psychiatrist with severe mental illness. (The Guardian)

The Biden Administration released new resources to help communities of gun violence.

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.